Lachman provides compliance, regulatory affairs and technical services for the pharmaceutical industry... Read more
Lachman provides compliance, regulatory affairs and technical services for the pharmaceutical industry... Read more
News
Dec 12, 2025
Lachman Consultants Blog
Lachman Consultants Blog EU AI Act Refresh: Speak Up and Problem Reporting Aspects Revised
Dec 09, 2025
Lachman Consultants Blog
Lachman Consultants Blog Rx to OTC Switches: New MaPP Provides Guidance and FDA Internal Policy
Dec 09, 2025
Lachman Consultants Blog
Lachman Consultants Blog Promotional Guidance for Biosimilars Tiptoes Around Interchangeability
Dec 08, 2025
Lachman Consultants Blog
Lachman Consultants Blog Unofficial November 2025 OGD Approval Actions - and a Side Note from a Shark
Dec 05, 2025
Lachman Consultants Blog
Lachman Consultants Blog Series of New and Revised PSGs Issued Today
Dec 03, 2025
Lachman Consultants Blog
Lachman Consultants Blog Court Rules FDA Erred in Not Granting Pediatric Rare Disease Voucher
Dec 02, 2025
Lachman Consultants Blog
Lachman Consultants Blog FDA's Interest in Increased Access to OTC Drugs-You Can Now Provide Feedback
Dec 01, 2025
Lachman Consultants Blog
Lachman Consultants Blog Why Was Only One ANDA Application Submitted in October 2025? Find the Answer Here!
Nov 26, 2025
Lachman Consultants Blog
Lachman Consultants Blog The Rise of Bio-Incubator Spaces: Redefining Asset Development in Life Sciences
Nov 26, 2025
Lachman Consultants Blog
Lachman Consultants Blog Wish for a Wonderful Thanksgiving in 2025 from Lachman Consultants
Lachman Consultants Competitors
1
2
3
4
5
6
7
8
9
10